• House For Patients
    • ALIMTA® (pemetrexed for injection)
    • CYRAMZA® (ramucirumab)
    • ERBITUX® (cetuximab)
    • Portrazza® (necitumumab)
    • RetevmoTM (selpercatinib)
    • Verzenio Continuous CareTM Support Program
  • For Healthcare Providers
    • ALIMTA® (pemetrexed for injection)
    • CYRAMZA® (ramucirumab)
    • ERBITUX® (cetuximab)
    • RetevmoTM (selpercatinib)
    • Verzenio® (abemaciclib)
  • Contact Us
Lilly Oncology Support Center


Welcome to the Lilly Oncology Support Center

Lilly Oncology is committed to helping you receive the care you need

Lilly is dedicated to developing treatments, but we're more than just our medicines. We’re determined to do our part to help patients and their loved ones.

Through the Lilly Oncology Support Center, we strive to offer personalized treatment support for eligible patients prescribed a Lilly Oncology product. For those who qualify, we can help with:

  • Understanding your insurance coverage
  • Review of financial-assistance options, including savings card programs and independent patient-assistance foundations
  • For some products we provide dedicated, personalized support through every step of treatment.



Woman and child looking out the window

On the following pages, you’ll find information on programs designed to address the financial challenges and access issues that some patients experience.

Choose a product:


ALIMTA® (pemetrexed for injection)

CYRAMZA® (ramucirumab)

ERBITUX® (cetuximab)

Portrazza® (necitumumab)

RetevmoTM (selpercatinib)

Verzenio® (abemaciclib)

Prescribing Information for ALIMTA® (pemetrexed for injection)
Patient Prescribing Information for ALIMTA® (pemetrexed for injection)
Prescribing Information for CYRAMZA® (ramucirumab)
Prescribing Information for ERBITUX® (cetuximab), including BOXED WARNING
Prescribing Information for Portrazza® (necitumumab), including BOXED WARNING
Prescribing Information for RetevmoTM (selpercatinib)
Patient Prescribing Information for RetevmoTM (selpercatinib)
Prescribing Information for Verzenio® (abemaciclib)
Patient Prescribing Information for Verzenio® (abemaciclib)
Terms of Use
Privacy Statement
Accessibility Statement
Sitemap

To speak to customer support:
Call 1-866-472-8663
Monday - Friday, 8am — 10pm ET

This site is intended for US residents ages 18 and over.

PP-OC-US-0369 08/2020 ©Lilly USA, LLC 2020. All rights reserved.

ALIMTA®, CYRAMZA®, ERBITUX®, Portrazza®, and Verzenio® are registered trademarks and RetevmoTM and Verzenio Continuous CareTM are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Terms of UsePrivacy StatementAccessibility StatementSitemap